SCHEMBL14736574

SCHEMBL14736574

CC(C)(C)OC(=O)NCCC(=O)OCC(=O)c1cccnc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.51
NAMPT P43490 2/20 0.47
ALDH1A1 P00352 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
CYP1A2 P05177 2/20 0.44
USP2 O75604 1/20 0.44
PLOD2 O00469 2/20 0.43
STING1 Q86WV6 1/20 0.43
PLOD3 O60568 1/20 0.42
PLOD1 Q02809 1/20 0.42
RAB9A P51151 2/20 0.42
LATS1 O95835 1/20 0.41
IDO1 P14902 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
AGTR1 P30556 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21423578 0.86 CYP3A4 (0.51) CYP3A4NAMPTALDH1A1MEN1KMT2A
SCHEMBL14736097 0.86 MAPT (0.49) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL25496036 0.83 CYP3A4 (0.60) CYP3A4NAMPTALDH1A1MEN1KMT2A
SCHEMBL29651385 0.83 CYP3A4 (0.60) CYP3A4NAMPTALDH1A1MEN1KMT2A
SCHEMBL2821346 0.80 NAMPT (0.54) CYP3A4NAMPTALDH1A1MEN1KMT2A
SCHEMBL15229186 0.80 RXFP1 (0.46) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL3402444 0.79 RAB9A (0.61) CYP3A4NAMPTALDH1A1MEN1KMT2A
SCHEMBL25332560 0.79 L3MBTL1 (0.56) CYP3A4NAMPTALDH1A1MEN1KMT2A
SCHEMBL14736142 0.79 ALDH1A1 (0.58) CYP3A4ALDH1A1MEN1KMT2ALMNA
Acetic Acid SCHEMBL28083299 0.76 KMT2A (0.60) CYP3A4NAMPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2753604-B1 PDE10 MODULATORS HOFFMANN LA ROCHE (CH) 2015-08-19 EP disclosed
US-8772510-B2 PDE10 modulators HOFFMANN-LA ROCHE INC. (US) 2014-07-08 US disclosed
EP-2574607-A1 PDE10 modulators F. Hoffmann-La Roche AG (CH) 2013-04-03 EP disclosed
WO-2013034506-A1 PDE10 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2013-03-14 WO disclosed
US-20130059833-A1 PDE10 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2013-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130059833-A1 PDE10 MODULATORS PDE10A, PDE5A, PDE2A CYP3A4 1490/4885NAMPT 2282/4885ALDH1A1 775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.